As the inaugural chief of IIB, Dr. Hildesheim built a multidisciplinary research program focused on the interplay of infection, immunity, and inflammation on cancer risk and helped translate those findings into important advances in cancer prevention, risk stratification, and screening. As an investigator, he devoted his career to the study of host and viral factors involved in the pathogenesis of DNA virus-related tumors.